Evogene Ltd Ord (EVGN)

$1.25 +0.01 (0.81%)
Market Cap 6.65M
Revenue (ttm) 8.51M
Net Income (ttm) -16.49M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -193.77%
Debt to Equity Ratio 0.00
Volume 69,000
Avg Vol 91,104
Day's Range N/A - N/A
Shares Out 5.37M
Stochastic %K 15%
Beta 1.56
Analysts Strong Sell
Price Target $3.00

Company Profile

Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Israel, Brazil, and internationally. The company focuses on product discovery and development in life-science based industries, including human health, agriculture, and other industrial applications through its computational predictive biology (CPB) platform. It operates through three segments: Agriculture, Human Health, and other Industrial Applications. The Agriculture segmen...

Industry: Biotechnology
Sector: Healthcare
Phone: 972 8 931 1900
Fax: 972 8 946 6724
Address:
13 Gad Feinstein Street, Park Rehovot, Rehovot, Israel
jjrrjjrr
jjrrjjrr Oct. 23 at 2:33 PM
$EVGN 🤫🤫
0 · Reply
SuperBusa
SuperBusa Oct. 21 at 3:44 PM
$EVGN
0 · Reply
SPYmyQQQ
SPYmyQQQ Oct. 20 at 8:22 PM
🚀 New Signal ✅ 💊 $EVGN 🗓️ Oct 20, 2025 💵 Entry: $1.27 🎯 Target (Opt.): $1.47 (+15.75%) 👉 FREE TRIAL! Check bio.
1 · Reply
Green_dillo
Green_dillo Oct. 14 at 11:58 PM
$EVGN 🤨
0 · Reply
suntanner20
suntanner20 Oct. 14 at 10:18 PM
$EVGN + $COOT agritech EVGN AI engines
0 · Reply
suntanner20
suntanner20 Oct. 14 at 9:27 PM
$EVGN 12 mill mkt cap(1.45 per share) = 12 mill cash / 15-20m revs in 2026 $SEED 24m mkt cap 2.20 few mill in cash $RKDA 8m mkt cap
0 · Reply
suntanner20
suntanner20 Oct. 14 at 8:52 PM
$EVGN should be 3.00 on Trump's ban of chinese cooking oil $SEED $RKDA
1 · Reply
unearthedmosquito
unearthedmosquito Oct. 14 at 8:32 PM
$EVGN whats this AH movement
0 · Reply
suntanner20
suntanner20 Oct. 14 at 11:44 AM
$EVGN Yaron and Ofer have NOT delivered the goods YET Low float and trades at cash with 0 debt Casterra alone is a 7.00 number post mega partner(s) announced with a runway to 14-21 The Chempass is worth 3.00 $AQMS $QMMM type of runner coming
0 · Reply
SuperBusa
SuperBusa Oct. 9 at 6:55 PM
$EVGN
0 · Reply
Latest News on EVGN
Evogene to Present at H.C. Wainwright 27th Annual Global Investment Conference in New York

Aug 28, 2025, 7:00 AM EDT - 2 months ago

Evogene to Present at H.C. Wainwright 27th Annual Global Investment Conference in New York

Evogene Ltd. (EVGN) Q2 2025 Earnings Call Transcript

Aug 19, 2025, 1:31 PM EDT - 2 months ago

Evogene Ltd. (EVGN) Q2 2025 Earnings Call Transcript

Evogene Reports Second Quarter 2025 Financial Results

Aug 19, 2025, 7:00 AM EDT - 2 months ago

Evogene Reports Second Quarter 2025 Financial Results

Evogene and Professor Ehud Gazit of Tel Aviv University Announce a Collaboration to Develop New Therapeutics for Metabolic Diseases

Aug 12, 2025, 7:00 AM EDT - 2 months ago

Evogene and Professor Ehud Gazit of Tel Aviv University Announce a Collaboration to Develop New Therapeutics for Metabolic Diseases

Evogene Schedules Second Quarter 2025 Financial Results Release

Jul 29, 2025, 7:00 AM EDT - 3 months ago

Evogene Schedules Second Quarter 2025 Financial Results Release

Evogene Announces Completion of Transaction for the Sale of Lavie Bio's Activity to ICL

Jul 8, 2025, 7:00 AM EDT - 3 months ago

Evogene Announces Completion of Transaction for the Sale of Lavie Bio's Activity to ICL

ICL

Evogene Announces Completion of First-In-Class Foundation Model for Generative Molecule Design, Developed in Collaboration with Google Cloud

Jun 10, 2025, 7:00 AM EDT - 4 months ago

Evogene Announces Completion of First-In-Class Foundation Model for Generative Molecule Design, Developed in Collaboration with Google Cloud

Evogene Ltd. (EVGN) Q1 2025 Earnings Call Transcript

May 21, 2025, 2:08 PM EDT - 5 months ago

Evogene Ltd. (EVGN) Q1 2025 Earnings Call Transcript

Evogene Reports First Quarter 2025 Financial Results

May 21, 2025, 7:00 AM EDT - 5 months ago

Evogene Reports First Quarter 2025 Financial Results

Evogene Schedules First Quarter 2025 Financial Results Release

May 8, 2025, 7:00 AM EDT - 6 months ago

Evogene Schedules First Quarter 2025 Financial Results Release

ICL to Acquire the Activity of Evogene's Subsidiary, Lavie Bio

Apr 21, 2025, 7:00 AM EDT - 6 months ago

ICL to Acquire the Activity of Evogene's Subsidiary, Lavie Bio

Evogene Ltd. (EVGN) Q4 2024 Earnings Call Transcript

Mar 6, 2025, 12:48 PM EST - 8 months ago

Evogene Ltd. (EVGN) Q4 2024 Earnings Call Transcript

Evogene Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 6, 2025, 7:15 AM EST - 8 months ago

Evogene Reports Fourth Quarter and Full Year 2024 Financial Results

Evogene Announces the Appointment of Nir Nimrodi as the New Chairperson of the Board, Effective March 5, 2025

Mar 6, 2025, 7:00 AM EST - 8 months ago

Evogene Announces the Appointment of Nir Nimrodi as the New Chairperson of the Board, Effective March 5, 2025

Evogene Schedules Fourth Quarter 2024 Financial Results Release

Feb 20, 2025, 7:00 AM EST - 8 months ago

Evogene Schedules Fourth Quarter 2024 Financial Results Release

AgPlenus Announces Discovery of a New Mode of Action for Fungicides Against Wheat Disease

Feb 13, 2025, 8:00 AM EST - 9 months ago

AgPlenus Announces Discovery of a New Mode of Action for Fungicides Against Wheat Disease

Evogene Ltd. (EVGN) Q3 2024 Earnings Call Transcript

Nov 21, 2024, 1:46 PM EST - 1 year ago

Evogene Ltd. (EVGN) Q3 2024 Earnings Call Transcript

Evogene Reports Third Quarter 2024 Financial Results

Nov 21, 2024, 7:30 AM EST - 1 year ago

Evogene Reports Third Quarter 2024 Financial Results

Lavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial Results

Nov 19, 2024, 7:00 AM EST - 1 year ago

Lavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial Results

Lavie Bio Announces Commercial Expansion of Yalos® as Seed-Treatment for Soybean, Following Successful Field Trials

Nov 12, 2024, 7:00 AM EST - 1 year ago

Lavie Bio Announces Commercial Expansion of Yalos® as Seed-Treatment for Soybean, Following Successful Field Trials

Evogene Schedules Third Quarter 2024 Financial Results Release

Nov 7, 2024, 7:00 AM EST - 1 year ago

Evogene Schedules Third Quarter 2024 Financial Results Release

Evogene Announces Collaboration with Google Cloud to Pioneer Generative AI Foundation Model for Novel Small Molecule Design

Oct 31, 2024, 8:00 AM EDT - 1 year ago

Evogene Announces Collaboration with Google Cloud to Pioneer Generative AI Foundation Model for Novel Small Molecule Design

Casterra Announces a Key Milestone in its Operational Expansion Plan in Africa, with Completion of First Shipment of Castor Seeds Grown and Processed in Kenya

Oct 29, 2024, 8:00 AM EDT - 1 year ago

Casterra Announces a Key Milestone in its Operational Expansion Plan in Africa, with Completion of First Shipment of Castor Seeds Grown and Processed in Kenya

Watershed AC, Evogene and Ben-Gurion University Receive Approval for Second Year Grant to Continue the Collaboration Focused on Improving Crustacean Traits Utilizing Gene Editing Technology

Oct 8, 2024, 7:00 AM EDT - 1 year ago

Watershed AC, Evogene and Ben-Gurion University Receive Approval for Second Year Grant to Continue the Collaboration Focused on Improving Crustacean Traits Utilizing Gene Editing Technology

Lavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of 'MicroFermentor', a Unique Technology that Can Change the Economics of Ag-Biologicals

Sep 30, 2024, 7:00 AM EDT - 1 year ago

Lavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of 'MicroFermentor', a Unique Technology that Can Change the Economics of Ag-Biologicals

Evogene Announces Pricing of US$5.5 Million Registered Direct Offering and Concurrent Private Placement

Aug 23, 2024, 8:55 AM EDT - 1 year ago

Evogene Announces Pricing of US$5.5 Million Registered Direct Offering and Concurrent Private Placement

Evogene Ltd. (EVGN) Q2 2024 Earnings Call Transcript

Aug 22, 2024, 5:42 PM EDT - 1 year ago

Evogene Ltd. (EVGN) Q2 2024 Earnings Call Transcript

Evogene Reports Second Quarter 2024 Financial Results

Aug 22, 2024, 7:00 AM EDT - 1 year ago

Evogene Reports Second Quarter 2024 Financial Results

Evogene Regains Compliance with Nasdaq Minimum Closing Bid Price Rule

Aug 12, 2024, 7:11 AM EDT - 1 year ago

Evogene Regains Compliance with Nasdaq Minimum Closing Bid Price Rule

Evogene Schedules Second Quarter 2024 Financial Results Release

Aug 12, 2024, 7:00 AM EDT - 1 year ago

Evogene Schedules Second Quarter 2024 Financial Results Release

Casterra Announces the Completion of a Successful Castor Seed Growing and Harvesting Season in Brazil

Jul 31, 2024, 7:00 AM EDT - 1 year ago

Casterra Announces the Completion of a Successful Castor Seed Growing and Harvesting Season in Brazil

Evogene Announces Expected Implementation of 1-for-10 Reverse Share Split

Jul 23, 2024, 8:48 AM EDT - 1 year ago

Evogene Announces Expected Implementation of 1-for-10 Reverse Share Split

ICL and Lavie Bio Leverage Artificial Intelligence to Make Significant Advancement in Development of Yield Increasing Bio-Stimulants

Jul 17, 2024, 8:00 AM EDT - 1 year ago

ICL and Lavie Bio Leverage Artificial Intelligence to Make Significant Advancement in Development of Yield Increasing Bio-Stimulants

ICL

Lavie Bio Announces Commercial Expansion of Yalos™ to Winter Wheat

Jul 2, 2024, 7:00 AM EDT - 1 year ago

Lavie Bio Announces Commercial Expansion of Yalos™ to Winter Wheat

Casterra Announces an Additional Purchase Order to Supply Castor Seeds to a New African Country

Jun 25, 2024, 7:00 AM EDT - 1 year ago

Casterra Announces an Additional Purchase Order to Supply Castor Seeds to a New African Country

Evogene Ltd. (EVGN) Q1 2024 Earnings Call Transcript

May 23, 2024, 4:57 PM EDT - 1 year ago

Evogene Ltd. (EVGN) Q1 2024 Earnings Call Transcript

Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based Therapeutic, BMC128, for Refractory RCC, NSCLC & Melanoma

May 23, 2024, 11:00 AM EDT - 1 year ago

Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based Therapeutic, BMC128, for Refractory RCC, NSCLC & Melanoma

Evogene Reports First Quarter 2024 Financial Results

May 23, 2024, 7:00 AM EDT - 1 year ago

Evogene Reports First Quarter 2024 Financial Results

Casterra Announces Additional Agreements with Seed Producers to Meet Existing & Growing Demand for its Elite Castor Seeds

May 21, 2024, 7:03 AM EDT - 1 year ago

Casterra Announces Additional Agreements with Seed Producers to Meet Existing & Growing Demand for its Elite Castor Seeds

Evogene Schedules First Quarter 2024 Financial Results Release

May 9, 2024, 7:00 AM EDT - 1 year ago

Evogene Schedules First Quarter 2024 Financial Results Release

Biomica to Present at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting

Apr 16, 2024, 7:00 AM EDT - 1 year ago

Biomica to Present at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting

Biomica to Present at Digestive Disease Week (DDW) Conference 2024 Annual Meeting

Apr 11, 2024, 7:00 AM EDT - 1 year ago

Biomica to Present at Digestive Disease Week (DDW) Conference 2024 Annual Meeting

Evogene and The Kitchen FoodTech Hub by Strauss Group Established Finally Foods Ltd. - Revolutionizing Protein Production in Plants for the Food Industry

Apr 2, 2024, 7:00 AM EDT - 1 year ago

Evogene and The Kitchen FoodTech Hub by Strauss Group Established Finally Foods Ltd. - Revolutionizing Protein Production in Plants for the Food Industry

Evogene Announces Filing of Annual Report on Form 20-F

Mar 28, 2024, 9:00 AM EDT - 1 year ago

Evogene Announces Filing of Annual Report on Form 20-F

Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification

Mar 20, 2024, 9:00 AM EDT - 1 year ago

Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification

Bayer AG and Lavie Bio Continue for Second Year of Biofungicides Validation Following Successful Lab and Greenhouse Testing

Mar 19, 2024, 9:00 AM EDT - 1 year ago

Bayer AG and Lavie Bio Continue for Second Year of Biofungicides Validation Following Successful Lab and Greenhouse Testing

Lavie Bio and Ceres Global Ag Corp. Collaborate to Include YalosTM Bio-Inoculant, in Regenerative Agriculture Initiatives in North America

Mar 13, 2024, 9:00 AM EDT - 1 year ago

Lavie Bio and Ceres Global Ag Corp. Collaborate to Include YalosTM Bio-Inoculant, in Regenerative Agriculture Initiatives in North America

Evogene Ltd. (EVGN) Q4 2023 Earnings Call Transcript

Mar 7, 2024, 1:35 PM EST - 1 year ago

Evogene Ltd. (EVGN) Q4 2023 Earnings Call Transcript

Evogene Reports Fourth Quarter and Full Year 2023 Financial Results

Mar 7, 2024, 7:00 AM EST - 1 year ago

Evogene Reports Fourth Quarter and Full Year 2023 Financial Results

AgPlenus Achieves Milestone in Collaboration with Corteva to Develop Novel Herbicides

Mar 6, 2024, 7:00 AM EST - 1 year ago

AgPlenus Achieves Milestone in Collaboration with Corteva to Develop Novel Herbicides

CTVA

jjrrjjrr
jjrrjjrr Oct. 23 at 2:33 PM
$EVGN 🤫🤫
0 · Reply
SuperBusa
SuperBusa Oct. 21 at 3:44 PM
$EVGN
0 · Reply
SPYmyQQQ
SPYmyQQQ Oct. 20 at 8:22 PM
🚀 New Signal ✅ 💊 $EVGN 🗓️ Oct 20, 2025 💵 Entry: $1.27 🎯 Target (Opt.): $1.47 (+15.75%) 👉 FREE TRIAL! Check bio.
1 · Reply
Green_dillo
Green_dillo Oct. 14 at 11:58 PM
$EVGN 🤨
0 · Reply
suntanner20
suntanner20 Oct. 14 at 10:18 PM
$EVGN + $COOT agritech EVGN AI engines
0 · Reply
suntanner20
suntanner20 Oct. 14 at 9:27 PM
$EVGN 12 mill mkt cap(1.45 per share) = 12 mill cash / 15-20m revs in 2026 $SEED 24m mkt cap 2.20 few mill in cash $RKDA 8m mkt cap
0 · Reply
suntanner20
suntanner20 Oct. 14 at 8:52 PM
$EVGN should be 3.00 on Trump's ban of chinese cooking oil $SEED $RKDA
1 · Reply
unearthedmosquito
unearthedmosquito Oct. 14 at 8:32 PM
$EVGN whats this AH movement
0 · Reply
suntanner20
suntanner20 Oct. 14 at 11:44 AM
$EVGN Yaron and Ofer have NOT delivered the goods YET Low float and trades at cash with 0 debt Casterra alone is a 7.00 number post mega partner(s) announced with a runway to 14-21 The Chempass is worth 3.00 $AQMS $QMMM type of runner coming
0 · Reply
SuperBusa
SuperBusa Oct. 9 at 6:55 PM
$EVGN
0 · Reply
SPACEDAD
SPACEDAD Oct. 9 at 6:10 PM
$EVGN adding here, started a position yesterday.
0 · Reply
dukenuke
dukenuke Oct. 9 at 5:34 PM
$EVGN somebody loaded up for something
1 · Reply
suntanner20
suntanner20 Oct. 9 at 12:38 PM
$EVGN https://agfundernews.com/molecular-farming-startup-finally-foods-raises-1-2m-strikes-deal-with-cbc-group
1 · Reply
suntanner20
suntanner20 Oct. 9 at 12:12 AM
$EVGN CFO is on dark mode. CEO was in NYC to see funds and now in Dark mode after saying many partners in touch with them for AI engines ; castor oil AG and Pharma compounds 18 months of cash 5-10 cmon
1 · Reply
KAMIKAZ3TIGER
KAMIKAZ3TIGER Oct. 8 at 11:29 PM
$EVGN My average is $3.69 - might start adding significantly to lower that to -$2.50.
0 · Reply
mangingriskandcandles
mangingriskandcandles Oct. 8 at 7:26 PM
$EVGN are you ready ?
0 · Reply
suntanner20
suntanner20 Oct. 8 at 5:27 PM
$MYSE and $EVGN low floats no debt cash on balance sheet game changing events coming triples to 10-20 baggers by Jan?!!
0 · Reply
suntanner20
suntanner20 Oct. 8 at 5:22 PM
$EVGN 1.45 on cusp of breaking out $QMMM $FOFO But this one has asset cash 0 debt and google behind their AI engines
0 · Reply
dukenuke
dukenuke Oct. 8 at 3:16 AM
$EVGN mysterious...
1 · Reply
dukenuke
dukenuke Oct. 8 at 12:34 AM
$EVGN 10 X average volume.
0 · Reply
suntanner20
suntanner20 Oct. 7 at 11:09 PM
$EVGN Mega oil companies or Ag companies want castor oil
0 · Reply
suntanner20
suntanner20 Oct. 7 at 10:57 PM
$EVGN any idea
0 · Reply